BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22072713)

  • 21. Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome.
    Cenini G; Dowling AL; Beckett TL; Barone E; Mancuso C; Murphy MP; Levine H; Lott IT; Schmitt FA; Butterfield DA; Head E
    Biochim Biophys Acta; 2012 Feb; 1822(2):130-8. PubMed ID: 22009041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction.
    Zhang W; Bai M; Xi Y; Hao J; Liu L; Mao N; Su C; Miao J; Li Z
    Free Radic Biol Med; 2012 Apr; 52(8):1443-52. PubMed ID: 22342520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid β-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide.
    Ma T; Hoeffer CA; Wong H; Massaad CA; Zhou P; Iadecola C; Murphy MP; Pautler RG; Klann E
    J Neurosci; 2011 Apr; 31(15):5589-95. PubMed ID: 21490199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.
    Fang F; Lue LF; Yan S; Xu H; Luddy JS; Chen D; Walker DG; Stern DM; Yan S; Schmidt AM; Chen JX; Yan SS
    FASEB J; 2010 Apr; 24(4):1043-55. PubMed ID: 19906677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation endproducts are deposited in neuronal hyaline inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
    Shibata N; Hirano A; Kato S; Nagai R; Horiuchi S; Komori T; Umahara T; Asayama K; Kobayashi M
    Acta Neuropathol; 1999 Mar; 97(3):240-6. PubMed ID: 10090670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
    Oulès B; Del Prete D; Greco B; Zhang X; Lauritzen I; Sevalle J; Moreno S; Paterlini-Bréchot P; Trebak M; Checler F; Benfenati F; Chami M
    J Neurosci; 2012 Aug; 32(34):11820-34. PubMed ID: 22915123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ.
    Ittner A; Asih PR; Tan ARP; Prikas E; Bertz J; Stefanoska K; Lin Y; Volkerling AM; Ke YD; Delerue F; Ittner LM
    Acta Neuropathol; 2020 Sep; 140(3):279-294. PubMed ID: 32725265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.
    Tomiyama T; Matsuyama S; Iso H; Umeda T; Takuma H; Ohnishi K; Ishibashi K; Teraoka R; Sakama N; Yamashita T; Nishitsuji K; Ito K; Shimada H; Lambert MP; Klein WL; Mori H
    J Neurosci; 2010 Apr; 30(14):4845-56. PubMed ID: 20371804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.
    He P; Zhong Z; Lindholm K; Berning L; Lee W; Lemere C; Staufenbiel M; Li R; Shen Y
    J Cell Biol; 2007 Aug; 178(5):829-41. PubMed ID: 17724122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOD1 mediates lysosome-to-mitochondria communication and its dysregulation by amyloid-β oligomers.
    Norambuena A; Sun X; Wallrabe H; Cao R; Sun N; Pardo E; Shivange N; Wang DB; Post LA; Ferris HA; Hu S; Periasamy A; Bloom GS
    Neurobiol Dis; 2022 Jul; 169():105737. PubMed ID: 35452786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease.
    Bayer TA; Schäfer S; Breyhan H; Wirths O; Treiber C; Multhaup G
    Clin Neuropathol; 2006; 25(4):163-71. PubMed ID: 16866297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment.
    Ostapchenko VG; Chen M; Guzman MS; Xie YF; Lavine N; Fan J; Beraldo FH; Martyn AC; Belrose JC; Mori Y; MacDonald JF; Prado VF; Prado MA; Jackson MF
    J Neurosci; 2015 Nov; 35(45):15157-69. PubMed ID: 26558786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease.
    Kam TI; Song S; Gwon Y; Park H; Yan JJ; Im I; Choi JW; Choi TY; Kim J; Song DK; Takai T; Kim YC; Kim KS; Choi SY; Choi S; Klein WL; Yuan J; Jung YK
    J Clin Invest; 2013 Jul; 123(7):2791-802. PubMed ID: 23921129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology.
    Münch G; Apelt J; Rosemarie-Kientsch-Engel ; Stahl P; Lüth HJ; Schliebs R
    J Neurochem; 2003 Jul; 86(2):283-9. PubMed ID: 12871569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.